Low NUDT15 expression levels due to bi-allelic NUDT15 variants and 6-mercaptopurine intolerance
6-Mercaptopurine (6-MP) is widely used for the treatment of pediatric leukemia and lymphoma. Recently, germline variants in the NUDT15 gene have been identified as one of the major genetic causes for 6-MP–associated adverse effects such as myelosuppression. Patients with hypomorphic NUDT15 variants...
Gespeichert in:
Veröffentlicht in: | British journal of haematology 2022-07, Vol.199 (2), p.270-276 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!